XML 15 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (UNAUDITED) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Condensed Consolidated Statement Of Operations        
Sales, net $ 1,947,570 $ 1,030,095 $ 4,506,508 $ 3,508,748
Cost of Sales 912,466 389,170 1,961,935 1,318,021
Gross Profit 1,035,104 640,925 2,544,573 2,190,727
Operating Expenses:        
Professional Fees 78,684 72,197 270,856 738,918
Depreciation and Amortization 153,572 145,760 468,778 453,834
Selling Expenses 368,733 319,807 1,004,393 870,287
Research and Development 129,924 79,747 372,234 128,512
Equity Compensation Expense (Note 7) 0 (20,597) 12,685 223,300
Consulting fees 19,711 63,293 93,089 180,405
General and Administrative 598,679 696,028 1,999,485 2,078,252
Other 0 (319,388) 0 (319,388)
Total Operating Expenses 1,349,303 1,036,848 4,221,520 4,354,121
Loss from Operations (314,199) (395,923) (1,676,947) (2,163,394)
Other Income (Expense):        
Amortization of Debt Discounts (7,851) (1,688) (23,792) (2,582)
Induced Conversion Costs 0 0 (57,201) 0
Interest Income 1,893 585 4,842 1,221
Interest Expense (53,000) (60,000) (168,878) (131,256)
Total Other Income (Expense) (58,958) (61,103) (245,029) (132,617)
Net Loss $ (373,158) $ (457,025) $ (1,921,977) $ (2,296,010)
Loss Per Share of Common Stock        
Basic and Diluted $ (0.00) $ (0.00) $ (0.02) $ (0.02)
Basic and Diluted Weighted Average Common Shares Outstanding 124,290,418 121,567,328 123,333,468 121,144,339